These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 26896226
1. Complications of Immunosuppressive Therapy in Solid Organ Transplantation. Katabathina V, Menias CO, Pickhardt P, Lubner M, Prasad SR. Radiol Clin North Am; 2016 Mar; 54(2):303-19. PubMed ID: 26896226 [Abstract] [Full Text] [Related]
2. Post-transplantation lymphoproliferative disorder: the spectrum of imaging appearances. Scarsbrook AF, Warakaulle DR, Dattani M, Traill Z. Clin Radiol; 2005 Jan; 60(1):47-55. PubMed ID: 15642292 [Abstract] [Full Text] [Related]
3. Posttransplant lymphoproliferative disorder: a pictorial review. Burney K, Bradley M, Buckley A, Lyburn I, Rye A, Hopkins R. Australas Radiol; 2006 Oct; 50(5):412-8. PubMed ID: 16981935 [Abstract] [Full Text] [Related]
4. Cutaneous involvement of polymorphic post-transplant lymphoproliferative disorder in a child after liver transplantation. Chen KY, Lin CY, Kuo TT, Shih LY, Chang CH, Chen WT, Yang CY. Pediatr Dermatol; 2019 Sep; 36(5):681-685. PubMed ID: 31215060 [Abstract] [Full Text] [Related]
5. Immunosuppressed solid organ transplant recipient. Stine JG, Shah N, Argo C. Gastroenterology; 2014 Feb; 146(2):345,590. PubMed ID: 24342810 [No Abstract] [Full Text] [Related]
6. Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience. Mendizabal M, Marciano S, dos Santos Schraiber L, Zapata R, Quiros R, Zanotelli ML, Rivas MM, Kusminsky G, Humeres R, Alves de Mattos A, Gadano A, Silva MO. Clin Transplant; 2013 Feb; 27(4):E469-77. PubMed ID: 23758407 [Abstract] [Full Text] [Related]
8. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment. Muti G, Cantoni S, Oreste P, Klersy C, Gini G, Rossi V, D'Avanzo G, Comoli P, Baldanti F, Montillo M, Nosari A, Morra E, Cooperative Study Group on PTLDs. Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467 [Abstract] [Full Text] [Related]
9. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation. Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ. Transpl Int; 2007 Mar; 20(3):207-18. PubMed ID: 17291214 [Abstract] [Full Text] [Related]
10. CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality. Rabot N, Büchler M, Foucher Y, Moreau A, Debiais C, Machet MC, Kessler M, Morelon E, Thierry A, Legendre C, Rivalan J, Kamar N, Dantal J. Transpl Int; 2014 Sep; 27(9):956-65. PubMed ID: 24964147 [Abstract] [Full Text] [Related]
11. Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines. Parker A, Bowles K, Bradley JA, Emery V, Featherstone C, Gupte G, Marcus R, Parameshwar J, Ramsay A, Newstead C, Haemato-oncology Task Force of the British Committee for Standards in Haematology and British Transplantation Society. Br J Haematol; 2010 Jun; 149(5):675-92. PubMed ID: 20408847 [Abstract] [Full Text] [Related]